Viewing Study NCT01267266


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-05-29 @ 9:39 AM
Study NCT ID: NCT01267266
Status: TERMINATED
Last Update Posted: 2015-04-01
First Post: 2010-12-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Saracatinib in Treating Patients With Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone-resistant Prostate Cancer View
None Recurrent Prostate Cancer View
None Stage IV Prostate Cancer View
Keywords: